Participants 397 493 7
Thirty social phobic patients (DSM-IV) were treated with either buspirone 30 mg daily or placebo
Participants 1164 1344 3
the study do not support the results of open studies, in which a reduction of social anxiety and social avoidance was reported in patients with social phobia treated with buspirone
